Nanoformulations for combination or cascade anticancer therapy

Miao, Lei, Guo, Shutao, Lin, C. Michael, Liu, Qi, Huang, Leaf·2017·Advanced Drug Delivery Reviews
DOI 10.1016/j.addr.2017.06.003

Cites (233)

Items 201–232 of 232

  1. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer
    Xiangyu Zhang, Qi Wang, Liubin Qin, Hao Fu, Yiwei Fang, Baoshan Han, Yourong Duan · 2016 · Drug Delivery
  2. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation
    Hao Zhang, Yong Tian, Zhenshu Zhu, Huae Xu, Xiaolin Li, Donghui Zheng, Wei‐Hao Sun · 2016 · Scientific Reports
  3. Spatiotemporally Controlled Co-delivery of Anti-vasculature Agent and Cytotoxic Drug by Octreotide-Modified Stealth Liposomes
    Wenbing Dai, Jin Wu, Junlin Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, You Wan, Qiang Zhang · 2012 · Pharmaceutical Research
  4. Curcumin Regulates Colon Cancer by Inhibiting P-Glycoprotein in In-situ Cancerous Colon Perfusion Rat Model
    Prasad Neerati · 2013 · Journal of Cancer Science & Therapy
  5. Actively targeting d -α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer
    Di Maria Jiang, Xiaoling Gao, Ting Kang, Xingye Feng, Jianhui Yao, Mengshi Yang, Yixian Jing, Qianqian Zhu, Jingxian Feng, Jun Chen · 2015 · Nanoscale
  6. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects
    Javier Hernández‐Gil, Macarena Cobaleda‐Siles, Aintzane Zabaleta, Luca Salassa, Javier Calvo, Juan C. Mareque Rivas · 2015 · Advanced Healthcare Materials
  7. Turning an antiviral into an anticancer drug: Nanoparticle delivery of acyclovir monophosphate
    Jing Yao, Yuan Zhang, Srinivas Ramishetti, Yuhua Wang, Leaf Huang · 2013 · Journal of Controlled Release
  8. Gas-generating TPGS-PLGA microspheres loaded with nanoparticles (NIMPS) for co-delivery of minicircle DNA and anti-tumoral drugs
    Vítor M. Gaspar, André Ferreira Moreira, Elisabete C. Costa, João António Queiroz, Fani Pereira de Sousa, Chantal Pichon, Ilídio Joaquim Correia · 2015 · Colloids and Surfaces B Biointerfaces
  9. Codelivery of Anticancer Drugs and siRNA By Mesoporous Silica Nanoparticles
    Mohammad Yahya Hanafi‐Bojd, Legha Ansari, Bizhan Malaekeh‐Nikouei · 2016 · Therapeutic Delivery
  10. A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
    Nai‐Jung Chiang, Tsu-Yi Chao, Ruey‐Kuen Hsieh, Cheng‐Hsu Wang, Yi-Wen Wang, C. Grace Yeh, Li‐Tzong Chen · 2016 · BMC Cancer
  11. Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids
    Odette G. Besançon, Godelieve A.M. Tytgat, Rutger Meinsma, René Leen, Jerry Hoebink, Ganna V. Kalayda, Ulrich Jaehde, Huib N. Caron, André B. P. Kuilenburg · 2011 · Cancer Letters
  12. An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors
    Peng Zhao, Guiquan Xia, Shuyun Dong, Zhong‐Xing Jiang, Mingnan Chen · 2016 · Biomaterials
  13. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association.
    Melissa A. Moss, Nicholas H. Varvel, Michael R. Nichols, Dana Kim Reed, Terrone L. Rosenberry · 2004 · PubMed
  14. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association
    Eunjung Lee, Changhwoa Oh, In‐San Kim, Ick Chan Kwon, Sehoon Kim · 2015 · Journal of Controlled Release
  15. Inhibitory Effect of Paclitaxel and Rapamycin Individual and Dual Drug-Loaded Polymeric Micelles in the Angiogenic Cascade
    Gyan Prakash Mishra, Duc At Nguyen, Adam W. G. Alani · 2013 · Molecular Pharmaceutics
  16. Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells
    Patrick Baum, Dafne Müller, Ronny Rüger, Roland E. Kontermann · 2007 · Journal of drug targeting
  17. Nanoparticle albumin-bound-paclitaxel: a limited improvement under the current therapeutic paradigm of pancreatic cancer
    Robert M. Hoffman, Michael Bouvet · 2015 · Expert Opinion on Pharmacotherapy
  18. Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy
    Shutao Guo, Yuhua Wang, Lei Miao, Zhenghong Xu, Ching-Hsuan M. Lin, Leaf Huang · 2014 · Biomaterials
  19. The Tumor Microenvironment as a Barrier to Cancer Nanotherapy
    Louis T. Curtis, Hermann B. Frieboes · 2016 · Advances in experimental medicine and biology
  20. Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer
    Tian, Jing, Min, Yuangzeng, Rodgers, Zachary, Wan, Xiaomeng, Qiu, Hui, Mi, Yu, Tian, Xi, Wagner, Kyle T., Caster, Joseph M., Qi, Yanfei et al. · 2017 · Nanomedicine: Nanotechnology, Biology and Medicine
  21. Synthesis and Characterization of AICAR and DOX Conjugated Multifunctional Nanoparticles as a Platform for Synergistic Inhibition of Cancer Cell Growth
    Cenk Dağlıoğlu, Burcu Okutucu · 2016 · Bioconjugate Chemistry
  22. FAK to the Rescue: Activated Stroma Promotes a “Safe Haven” for BRAF-Mutant Melanoma Cells by Inducing FAK Signaling
    Frame, Margaret C., Serrels, Alan · 2015 · Cancer Cell
  23. Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
    Chun-Te Chiang, Pei-Yen Yeh, Ming Gao, Chun-Wei David Chen, Ling-Chun Yeh, Wen-Chi Feng, Sung‐Hsin Kuo, Chih‐Hung Hsu, Yen‐Shen Lu, Ann‐Lii Cheng · 2010 · Cancer Letters
  24. The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine
    Kaley D. Wilson, Susan D. de Jong, Mikameh Kazem, Ryan Lall, Michael J. Hope, Pieter R. Cullis, Ying K. Tam · 2008 · The Journal of Gene Medicine
  25. Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging
    Srinivas Ramishetti, Andrew Satterlee, Yuhua Wang, Yuan Zhang, Yongjun Wang, Leaf Huang · 2015 · Nanoscale
  26. Therapeutic Effects of AICAR and DOX Conjugated Multifunctional Nanoparticles in Sensitization and Elimination of Cancer Cells via Survivin Targeting
    Cenk Dağlıoğlu, Burcu Okutucu · 2016 · Pharmaceutical Research
  27. Bevacizumab plus Irinotecan-, Fluorouracil-, and Leucovorin-Based Chemotherapy with Concomitant HAART in an HIV-Positive Patient with Metastatic Colorectal Cancer
    Massimiliano Berretta, Arben Lleshi, Ernesto Zanet, Alessandra Bearz, Cecilia Simonelli, Rossella Fisichella, Guglielmo Nasti, Salvatore Berretta, Umberto Tirelli · 2008 · Onkologie
  28. Sensitizing nanoparticle based platinum(IV) drugs by curcumin for better chemotherapy
    Xiang Kang, Zhao Chen, Lesan Yan, Ruogu Qi, Xiabin Jing, Zehua Wang · 2016 · Colloids and Surfaces B Biointerfaces
  29. Carboplatin—gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration
    Constantin A Dasanu, Thomas J. Herzog, Doru T Alexandrescu · 2009 · Journal of Oncology Pharmacy Practice
  30. Repetitive responses to nanoparticle albumin‐bound paclitaxel and carboplatin in malignant pleural mesothelioma
    Osamu Kanai, Kohei Fujita, Koichi Nakatani, Tadashi Mio · 2016 · Respirology Case Reports
  31. [Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].
    Jun Chen, Yuan Yw, Zhang, Zhou Dy · 2002 · PubMed
  32. Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities
    Ebuzer Kalyoncu, Tolga Tarkan Ölmez, Alper Devrim Özkan, Ömer Faruk Sarıoğlu · 2016 · Current Pharmaceutical Design